These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19274366)

  • 1. How to establish a successful revolving drug fund: the experience of Khartoum state in the Sudan.
    Ali GK
    Bull World Health Organ; 2009 Feb; 87(2):139-42. PubMed ID: 19274366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achieving sustainability, quality and access: lessons from the world's largest revolving drug fund in Khartoum.
    Witter S
    East Mediterr Health J; 2007; 13(6):1476-85. PubMed ID: 18341197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overdependence on For-Profit Pharmacies: A Descriptive Survey of User Evaluation of Medicines Availability in Public Hospitals in Selected Nigerian States.
    Ushie BA; Ugal DB; Ingwu JA
    PLoS One; 2016; 11(11):e0165707. PubMed ID: 27812177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the Bamako-Initiative drug revolving fund on availability and rational use of essential drugs in primary health care facilities in south-east Nigeria.
    Uzochukwu BS; Onwujekwe OE; Akpala CO
    Health Policy Plan; 2002 Dec; 17(4):378-83. PubMed ID: 12424209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Health Impact Fund: incentives for improving access to medicines.
    Banerjee A; Hollis A; Pogge T
    Lancet; 2010 Jan; 375(9709):166-9. PubMed ID: 20109894
    [No Abstract]   [Full Text] [Related]  

  • 6. Revolving drug funds: conducting business in the public sector.
    Cross PN; Huff MA; Quick JD; Bates JA
    Soc Sci Med; 1986; 22(3):335-43. PubMed ID: 3515574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 8. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
    Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
    Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affordable and equitable access to subsidised outpatient medicines? Analysis of co-payments under the Additional Drug Package in Kyrgyzstan.
    Vogler S; Schneider P; Dedet G; Bak Pedersen H
    Int J Equity Health; 2019 Jun; 18(1):89. PubMed ID: 31196109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
    Ewen M; Zweekhorst M; Regeer B; Laing R
    PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of a revolving drug fund for essential asthma medicines in Benin.
    Agodokpessi G; Aït-Khaled N; Gninafon M; Tawo L; Bekou W; Perrin C; Bissell K; Billo N; Enarson DA; Chiang CY
    J Pharm Policy Pract; 2015; 8(1):12. PubMed ID: 25914829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revolving drug funds at front-line health facilities in Vientiane, Lao PDR.
    Murakami H; Phommasack B; Oula R; Sinxomphou S
    Health Policy Plan; 2001 Mar; 16(1):98-106. PubMed ID: 11238436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatima Suleman: making medicines more widely available.
    Bull World Health Organ; 2017 Dec; 95(12):800-801. PubMed ID: 29200520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Revolving Fund Pharmacy Model: backing up the Ministry of Health supply chain in western Kenya.
    Manji I; Manyara SM; Jakait B; Ogallo W; Hagedorn IC; Lukas S; Kosgei EJ; Pastakia SD
    Int J Pharm Pract; 2016 Oct; 24(5):358-66. PubMed ID: 26913925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supply-chain strategies for essential medicines in rural western Kenya during COVID-19.
    Tran DN; Were PM; Kangogo K; Amisi JA; Manji I; Pastakia SD; Vedanthan R
    Bull World Health Organ; 2021 May; 99(5):388-392. PubMed ID: 33958827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Availability, affordability, and prescribing pattern of medicines in Sudan.
    Cheraghali AM; Idries AM
    Pharm World Sci; 2009 Apr; 31(2):209-15. PubMed ID: 19263235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the consequences of decentralization: has privatization of health services been the perceived effect of decentralization in Khartoum locality, Sudan?
    Noory B; Hassanain SA; Lindskog BV; Elsony A; Bjune GA
    BMC Health Serv Res; 2020 Jul; 20(1):669. PubMed ID: 32690003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parents' and guardians' perceptions on availability and pricing of medicines and healthcare for children in eThekwini, South Africa - a qualitative study.
    Perumal-Pillay VA; Suleman F
    BMC Health Serv Res; 2017 Jun; 17(1):417. PubMed ID: 28629443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Availability, prices and affordability of essential medicines for children: a cross-sectional survey in Jiangsu Province, China.
    Sun X; Wei J; Yao Y; Chen Q; You D; Xu X; Dai J; Yao Y; Sheng J; Li X
    BMJ Open; 2018 Oct; 8(10):e023646. PubMed ID: 30341137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The essential drugs concept is needed now more than ever.
    Smith MK; Tickell S
    Trans R Soc Trop Med Hyg; 2003; 97(1):2-5. PubMed ID: 12886792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.